
Jehanne Souaya Sitton
Examiner (ID: 9654)
| Most Active Art Unit | 1634 |
| Art Unit(s) | 1655, 1634, 1682 |
| Total Applications | 1444 |
| Issued Applications | 515 |
| Pending Applications | 318 |
| Abandoned Applications | 641 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 20264401
[patent_doc_number] => 12435379
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-10-07
[patent_title] => BTK mutation and ibrutinib resistance
[patent_app_type] => utility
[patent_app_number] => 17/399831
[patent_app_country] => US
[patent_app_date] => 2021-08-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 10
[patent_no_of_words] => 13539
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17399831
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/399831 | BTK mutation and ibrutinib resistance | Aug 10, 2021 | Issued |
Array
(
[id] => 19904363
[patent_doc_number] => 12281359
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-04-22
[patent_title] => Variants of TNFSF15 and DCR3 associated with Crohn's disease
[patent_app_type] => utility
[patent_app_number] => 17/392098
[patent_app_country] => US
[patent_app_date] => 2021-08-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 1536
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 95
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17392098
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/392098 | Variants of TNFSF15 and DCR3 associated with Crohn's disease | Aug 1, 2021 | Issued |
Array
(
[id] => 17214898
[patent_doc_number] => 20210348235
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-11
[patent_title] => GENETIC MARKERS ASSOCIATED WITH RESPONSE TO CRTH2 RECEPTOR ANTAGONISTS
[patent_app_type] => utility
[patent_app_number] => 17/377514
[patent_app_country] => US
[patent_app_date] => 2021-07-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20133
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -3
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17377514
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/377514 | GENETIC MARKERS ASSOCIATED WITH RESPONSE TO CRTH2 RECEPTOR ANTAGONISTS | Jul 15, 2021 | Abandoned |
Array
(
[id] => 17822916
[patent_doc_number] => 11427855
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2022-08-30
[patent_title] => Compositions and methods for pairwise sequencing
[patent_app_type] => utility
[patent_app_number] => 17/377283
[patent_app_country] => US
[patent_app_date] => 2021-07-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 86
[patent_figures_cnt] => 120
[patent_no_of_words] => 139255
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 235
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17377283
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/377283 | Compositions and methods for pairwise sequencing | Jul 14, 2021 | Issued |
Array
(
[id] => 18125075
[patent_doc_number] => 20230010690
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-01-12
[patent_title] => METHOD AND SYSTEM OF DIAGNOSING AND TREATING NEURODEGENERATIVE DISEASE AND SEIZURES
[patent_app_type] => utility
[patent_app_number] => 17/305480
[patent_app_country] => US
[patent_app_date] => 2021-07-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11156
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 119
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17305480
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/305480 | METHOD AND SYSTEM OF DIAGNOSING AND TREATING NEURODEGENERATIVE DISEASE AND SEIZURES | Jul 7, 2021 | Pending |
Array
(
[id] => 18552468
[patent_doc_number] => 20230250478
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-10
[patent_title] => DIAGNOSIS AND TREATMENT OF CHRONIC DIABETIC COMPLICATIONS USING LONG NONCODING RNAS AS TARGETS
[patent_app_type] => utility
[patent_app_number] => 18/014322
[patent_app_country] => US
[patent_app_date] => 2021-07-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 39876
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18014322
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/014322 | DIAGNOSIS AND TREATMENT OF CHRONIC DIABETIC COMPLICATIONS USING LONG NONCODING RNAS AS TARGETS | Jul 5, 2021 | Pending |
Array
(
[id] => 18676779
[patent_doc_number] => 20230314408
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-05
[patent_title] => IMMUNE PROFILING AND METHODS OF USING SAME TO PREDICT RESPONSIVENESS TO AN IMMUNOTHERAPY AND TREAT CANCER
[patent_app_type] => utility
[patent_app_number] => 18/014053
[patent_app_country] => US
[patent_app_date] => 2021-07-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11048
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 179
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18014053
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/014053 | IMMUNE PROFILING AND METHODS OF USING SAME TO PREDICT RESPONSIVENESS TO AN IMMUNOTHERAPY AND TREAT CANCER | Jul 1, 2021 | Pending |
Array
(
[id] => 18612765
[patent_doc_number] => 20230279501
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-07
[patent_title] => Bone Morphogenetic Protein-8B (BMP8B) as marker and therapeutic target for liver fibrosis or liver cancer
[patent_app_type] => utility
[patent_app_number] => 18/011569
[patent_app_country] => US
[patent_app_date] => 2021-06-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8851
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18011569
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/011569 | Bone Morphogenetic Protein-8B (BMP8B) as marker and therapeutic target for liver fibrosis or liver cancer | Jun 27, 2021 | Pending |
Array
(
[id] => 17168769
[patent_doc_number] => 20210322439
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-21
[patent_title] => COMPOSITIONS AND METHODS FOR TREATING PATIENTS WITH RTK MUTANT CELLS
[patent_app_type] => utility
[patent_app_number] => 17/356128
[patent_app_country] => US
[patent_app_date] => 2021-06-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22974
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17356128
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/356128 | COMPOSITIONS AND METHODS FOR TREATING PATIENTS WITH RTK MUTANT CELLS | Jun 22, 2021 | Abandoned |
Array
(
[id] => 18610875
[patent_doc_number] => 20230277605
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-07
[patent_title] => WHOLE BACTERIA CAPSULE, PREPARATION METHOD THEREFOR AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/005380
[patent_app_country] => US
[patent_app_date] => 2021-06-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4954
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18005380
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/005380 | WHOLE BACTERIA CAPSULE, PREPARATION METHOD THEREFOR AND USE THEREOF | Jun 17, 2021 | Pending |
Array
(
[id] => 17400015
[patent_doc_number] => 20220042105
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-10
[patent_title] => COMPOSITIONS AND METHODS FOR SCREENING AND DIAGNOSIS OF PROSTATE CANCER
[patent_app_type] => utility
[patent_app_number] => 17/350833
[patent_app_country] => US
[patent_app_date] => 2021-06-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8756
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17350833
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/350833 | Compositions and methods for screening and diagnosis of prostate cancer | Jun 16, 2021 | Issued |
Array
(
[id] => 19738566
[patent_doc_number] => 12215386
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-02-04
[patent_title] => Blood biomarkers for appendicitis and diagnostics methods using biomarkers
[patent_app_type] => utility
[patent_app_number] => 17/343285
[patent_app_country] => US
[patent_app_date] => 2021-06-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 8
[patent_no_of_words] => 14201
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 86
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17343285
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/343285 | Blood biomarkers for appendicitis and diagnostics methods using biomarkers | Jun 8, 2021 | Issued |
Array
(
[id] => 20241251
[patent_doc_number] => 12421560
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-09-23
[patent_title] => Assays for the detection of SARS-CoV-2 mutants
[patent_app_type] => utility
[patent_app_number] => 17/338774
[patent_app_country] => US
[patent_app_date] => 2021-06-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 10
[patent_no_of_words] => 23586
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 70
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17338774
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/338774 | Assays for the detection of SARS-CoV-2 mutants | Jun 3, 2021 | Issued |
Array
(
[id] => 18452111
[patent_doc_number] => 20230193390
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-22
[patent_title] => DETECTING A CHROMOSOME CONFIRMATION AS MARKER FOR FIBROSIS, E.G. SLERODERMA
[patent_app_type] => utility
[patent_app_number] => 18/000243
[patent_app_country] => US
[patent_app_date] => 2021-06-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 47114
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 103
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18000243
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/000243 | DETECTING A CHROMOSOME CONFIRMATION AS MARKER FOR FIBROSIS, E.G. SLERODERMA | Jun 1, 2021 | Pending |
Array
(
[id] => 17299986
[patent_doc_number] => 20210395825
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-23
[patent_title] => URINE BIOMARKERS FOR DETECTING GRAFT REJECTION
[patent_app_type] => utility
[patent_app_number] => 17/335327
[patent_app_country] => US
[patent_app_date] => 2021-06-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6630
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 142
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17335327
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/335327 | URINE BIOMARKERS FOR DETECTING GRAFT REJECTION | May 31, 2021 | Pending |
Array
(
[id] => 18469312
[patent_doc_number] => 20230203596
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-29
[patent_title] => A METHOD OF DIAGNOSING, PROGNOSING AND/OR MONITORING OVARIAN CANCER
[patent_app_type] => utility
[patent_app_number] => 18/000178
[patent_app_country] => US
[patent_app_date] => 2021-05-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17142
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 104
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18000178
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/000178 | A METHOD OF DIAGNOSING, PROGNOSING AND/OR MONITORING OVARIAN CANCER | May 27, 2021 | Pending |
Array
(
[id] => 19904366
[patent_doc_number] => 12281362
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-04-22
[patent_title] => Diagnostic tools and treatments for clear cell renal cell carcinoma
[patent_app_type] => utility
[patent_app_number] => 17/327100
[patent_app_country] => US
[patent_app_date] => 2021-05-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 36
[patent_figures_cnt] => 39
[patent_no_of_words] => 8707
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 162
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17327100
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/327100 | Diagnostic tools and treatments for clear cell renal cell carcinoma | May 20, 2021 | Issued |
Array
(
[id] => 17292615
[patent_doc_number] => 20210388454
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-16
[patent_title] => RAPID DIAGNOSTIC SYSTEM USING TARGETED ANTISENSE OLIGONUCLEOTIDE CAPPED PLASMONIC NANOPARTICLES
[patent_app_type] => utility
[patent_app_number] => 17/325839
[patent_app_country] => US
[patent_app_date] => 2021-05-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12730
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 161
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17325839
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/325839 | RAPID DIAGNOSTIC SYSTEM USING TARGETED ANTISENSE OLIGONUCLEOTIDE CAPPED PLASMONIC NANOPARTICLES | May 19, 2021 | Pending |
Array
(
[id] => 17292615
[patent_doc_number] => 20210388454
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-16
[patent_title] => RAPID DIAGNOSTIC SYSTEM USING TARGETED ANTISENSE OLIGONUCLEOTIDE CAPPED PLASMONIC NANOPARTICLES
[patent_app_type] => utility
[patent_app_number] => 17/325839
[patent_app_country] => US
[patent_app_date] => 2021-05-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12730
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 161
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17325839
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/325839 | RAPID DIAGNOSTIC SYSTEM USING TARGETED ANTISENSE OLIGONUCLEOTIDE CAPPED PLASMONIC NANOPARTICLES | May 19, 2021 | Pending |
Array
(
[id] => 18436527
[patent_doc_number] => 20230183821
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-15
[patent_title] => FIELD METHOD FOR DETECTING THE PRESENCE AND MULTI-RESISTANCE OF A PEST, IN PARTICULAR ZYMOSEPTORIA TRITICI, IN CEREAL CROPS
[patent_app_type] => utility
[patent_app_number] => 17/999326
[patent_app_country] => US
[patent_app_date] => 2021-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4485
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 76
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17999326
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/999326 | FIELD METHOD FOR DETECTING THE PRESENCE AND MULTI-RESISTANCE OF A PEST, IN PARTICULAR ZYMOSEPTORIA TRITICI, IN CEREAL CROPS | May 16, 2021 | Pending |